Slimdia Revolution Dietary Supplement Recalled Due to Significant Health Risk
P&J Trading is conducting a voluntary recall of its Slimdia Revolution dietary supplement after U.S. Food and Drug Administration (FDA) testing found that the product contains Sibutramine.
Sibutramine is an appetite suppressant that was FDA-approved for the treatment of obesity. It is a Schedule IV controlled substance and because of the risks associated with its use, it should be taken only under the direct supervision of qualified health care professional.
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant health risk to patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. Sibutramine has been withdrawn from the U.S. marketplace.
Slimdia Revolution was distributed and sold nationwide in the U.S. from March 2012 to December 2012.
P&J Trading advises any consumers in possession of Slimdia Revolution to return any unused product directly to the company for a full refund. Consumers can call 714-726-6544 for instructions on the Slimdia Revolution return and refund process.